Protagenic Therapeutics, Inc.\new annual capital expenditures (capex)
2014
2015
2015
2022
2023
2026
Protagenic Therapeutics, Inc.\new Capital Expenditures (CapEx) Growth & History (PTIX)
Protagenic Therapeutics, Inc.\new's capital expenditures (capex) was $3,297 for fiscal 2026.
View full Protagenic Therapeutics, Inc.\new company overviewProtagenic Therapeutics, Inc.\new annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | $3,297 | — | — |
| 2023 | 2023-12-31 | $149,775 | $147,970 | +8197.78% |
| 2022 | 2022-12-31 | $1,805 | — | — |
| 2015 · Dec 31 | 2015-12-31 | $1,791 | — | — |
| 2015 · Jun 30 | 2015-06-30 | $1,000 | $0 | 0.00% |
| 2014 | 2014-06-30 | $1,000 | — | — |
Protagenic Therapeutics, Inc.\new quarterly capital expenditures (capex)
Q3.11
Q3.11
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q4.24
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q4 2024 | 2024-12-31 | $157,044 | — | — |
| Q4 2015 | 2015-06-30 | $0 | $0 | — |
| Q3 2015 | 2015-03-31 | $1,000 | $1,000 | — |
| Q2 2015 | 2014-12-31 | $0 | $0 | — |
| Q1 2015 | 2014-09-30 | $0 | −$1,000 | — |
| Q4 2014 | 2014-06-30 | $0 | — | — |
| Q3 2014 | 2014-03-31 | $0 | — | — |
| Q2 2014 | 2013-12-31 | $0 | — | — |
| Q1 2014 | 2013-09-30 | $1,000 | — | — |
| Q3 2011 · Sep 30 | 2011-09-30 | $220,000 | $217,000 | +7233.33% |
| Q3 2011 · Sep 30 | 2010-09-30 | $3,000 | — | — |
Protagenic Therapeutics, Inc.\new capital expenditures (capex) trends
Between the periods ended 2014-06-30 and 2026-03-31, Protagenic Therapeutics, Inc.\new's capital expenditures (capex) increased from $1,000 to $3,297, a change of $2,297. The latest reported quarter, Q4 2024, shows $157,044.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Protagenic Therapeutics, Inc.\new source filings ↗